Related Experiment Video
Updated: Jan 21, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
An Efficient Computational Assay for β-Lactam Antibiotic Breakdown by Class A β-Lactamases
Viivi H A Hirvonen1,2, Katharine Hammond2, Ewa I Chudyk2
1School of Biochemistry , University of Bristol , University Walk, Bristol BS8 1TD , United Kingdom.
A new computational method efficiently predicts beta-lactamase activity against carbapenems, aiding antibiotic resistance research. This simulation tool accelerates the evaluation of new beta-lactamase variants and antibiotic development.
Area of Science:
- Biochemistry
- Computational Chemistry
- Pharmacology
Background:
- Class A beta-lactamases confer resistance to beta-lactam antibiotics.
- Carbapenem antibiotics are crucial, making their degradation by beta-lactamases a significant clinical concern.
- Existing methods for evaluating beta-lactamase activity can be time-consuming and complex.
Purpose of the Study:
- To develop and validate an efficient computational protocol for predicting beta-lactamase activity against carbapenems.
- To reduce the computational cost and complexity of assessing beta-lactamase-mediated antibiotic resistance.
- To gain mechanistic insights into beta-lactam breakdown by these enzymes.
Main Methods:
- Utilized a Quantum Mechanics/Molecular Mechanics (QM/MM) molecular simulation approach.
- Developed an efficient protocol requiring less than 24 CPU hours per simulation.
- The method does not necessitate experimental data fitting or extensive parametrization.
Main Results:
- The QM/MM protocol accurately predicts the activity of Class A beta-lactamases against carbapenems.
- Achieved a computational time reduction exceeding 99% compared to traditional methods.
- The simulations provided detailed mechanistic information on the breakdown of beta-lactam antibiotics.
Conclusions:
- The developed computational assay is a rapid and accurate tool for evaluating beta-lactamase activity.
- This approach can significantly aid in the assessment of emerging beta-lactamase variants.
- The protocol holds promise for accelerating the development of novel antibiotics to combat resistance.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
TGF - β Signaling Pathway
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Antihypertensive Drugs: Types of β-Blockers
Heart Failure Drugs: β-Blockers

